7/23/2020 6:01:25 AM
Danaher Q2 EPS $1.24 Vs $0.90 Last Year
7/16/2020 7:09:04 AM
Foundation For Innovative New Diagnostics And Cepheid Announce The Launch Of New Xpert MTB/XDR Test
6/29/2020 8:07:46 AM
Beckman Coulter Says SARS-CoV-2 IgG Antibody Test Gets FDA Emergency Use Authorization
6/9/2020 7:01:39 AM
Cepheid Announces Development Of Four-in-One Combination Test For SARS-CoV-2, Flu A, Flu B And RSV
5/12/2020 4:15:30 PM
Danaher Announces Closing Of Common Stock Offering
5/8/2020 1:18:53 AM
Danaher Prices Offerings Of 9.51 Mln Shares At $163/Shr And 1.55 Mln Shares Of 5.00% Series B Preferred Stock
5/7/2020 8:44:09 AM
Danaher Begins Concurrent Offerings Of $1.25 Bln Of Common Stock And $1.25 Bln Of Shares Of Preferred Stock
5/6/2020 4:12:27 PM
Danaher Q1 EPS $0.81 Vs $0.45 Last Year; Names Rainer Blair To Succeed Thomas Joyce As President And CEO
5/5/2020 4:12:46 PM
Danaher Corp. (DHR) Declares Quarterly Dividend of $ 0.18, Record Date 6/26/2020
4/30/2020 9:05:06 AM
Danaher Completes Sale Of Certain Businesses To Sartorius AG To Satisfy Regulatory Requirement For Cytiva Acquisition
4/13/2020 6:52:49 AM
Danaher Expects Q1 Revenue Growth Of 3.0% And Non-GAAP Core Revenue Growth Of 4.5%; Withdraws 2020 Guidance